Home

Parmax Pharma Ltd PE Ratio

Image

Parmax Pharma Ltd

NSE: PARMAXPHARMA

PE

-

Last updated on: Apr 28, 2025

Key Highlights

  • The P/E Ratio of Parmax Pharma Ltd is 0 as of 28 Apr 9.00 AM .
  • The P/E Ratio of Parmax Pharma Ltd changed from 21 on March 2021 to 0 on March 2024 . This represents a CAGR of -100.00% over 4 years.
  • The Latest Trading Price of Parmax Pharma Ltd is ₹ 44.99 as of 28 Apr 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 39.9 in 5 years. This represents a CAGR of 13.70%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.1. The PE Ratio of Pharmaceuticals industry is 39.9. The PE Ratio of Retail industry is 159.2. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Parmax Pharma Ltd

No data available

Company Fundamentals for Parmax Pharma Ltd

Image

Parmax Pharma Ltd

NSE: PARMAXPHARMA

Share Price

₹ 44.99

-0.29 (-0.64%)

stock direction

Last updated on: Apr 28, 2025

Market Price of Parmax Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Parmax Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
28 Apr 202544.99
25 Apr 202545.28
24 Apr 202545.98
23 Apr 202545
22 Apr 202545
21 Apr 202545.9
17 Apr 202539.12
16 Apr 202543
15 Apr 202543.25
11 Apr 202548.94

BlinkX Score for Parmax Pharma Ltd

Asset Value vs Market Value of Parmax Pharma Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Parmax Pharma Ltd16.83
Sun Pharmaceutical Industries Ltd441910
Divis Laboratories Ltd160035
Cipla Ltd125536
Torrent Pharmaceuticals Ltd112888
Mankind Pharma Ltd105587

PE Ratio of Parmax Pharma Ltd Explained

16.83

Market cap

-2

Earnings

0.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Parmax Pharma Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Parmax Pharma Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Parmax Pharma Ltd

No data available

* All values are in %

About Parmax Pharma Ltd

  • Incorporated in Nov.'94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara.
  • The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax's pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc.
  • The Company then discontinued their business activities for few years due to various reasons.
  • Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994; the Company had set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA.

Parmax Pharma Ltd News Hub

Parmax Pharma reports standalone net profit of Rs 0.01 crore in the June 2024 quarter

Net profit of Parmax Pharma reported to Rs 0.01 crore in the quarter ended June 2024 as against net

Read more

16 Aug 24

Parmax Pharma to declare Quarterly Result

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 14 August 2024. Powere

Read more

09 Aug 24

Parmax Pharma to conduct AGM

Parmax Pharma announced that the Annual General Meeting (AGM) of the company will be held on 30 Sept

Read more

18 Sept 24

Parmax Pharma to discuss results

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 14 November 2024 Power

Read more

07 Nov 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Parmax Pharma Ltd

What is the current PE Ratio of Parmax Pharma Ltd?

The Current PE Ratio of Parmax Pharma Ltd is 0.0 as on 28 Apr 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 39.9 as on 28 Apr 2025.

What was the PE Ratio of Parmax Pharma Ltd last year?

The PE Ratio of Parmax Pharma Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Parmax Pharma Ltd indicate about its stock?

The PE Ratio of Parmax Pharma Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Parmax Pharma Ltd.

What is the PE Ratio Growth of Parmax Pharma Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Parmax Pharma Ltd grew by -% whereas, the EPS ratio grew by 81.0.

How does the PE ratio of Parmax Pharma Ltd compare to industry peers?

The PE ratio of Parmax Pharma Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Parmax Pharma Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Parmax Pharma Ltd PE Ratio.

What factors influence the PE ratio of Parmax Pharma Ltd PE Ratio?

The PE ratio of Parmax Pharma Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Parmax Pharma Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Parmax Pharma Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Parmax Pharma Ltd PE Ratio?

You can check the latest PE ratio of Parmax Pharma Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Parmax Pharma Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Parmax Pharma Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Parmax Pharma Ltd PE Ratio predict future stock performance?

While the Parmax Pharma Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions